Longitudinal Studies of Blood‐Based Biomarkers for Dementia in Primary Care: A Systematic Review and Meta‐Analysis

Abstract

Background: There is an urgent need for population‐specific predictive risk models for dementia that address earlier stages of the disease continuum. Blood‐based biomarkers (BBMs) have demonstrated excellent discrimination in high pre‐test probability populations, such as memory clinics.